Comparative studies on Effect of Jadelle, Depoproveral and implanon Contraceptives on APOA1 and APO B Concentration in Females Attending a Tertiary Hospital in Southern Nigeria
Keywords:
Implanon, Jadelle, Depo-provera, Apo A1, Apo BAbstract
Background: Apolipoproteins function as structural components of lipoprotein particles, cofactors for enzymes and ligands for cell-surface receptors. Apo A1 a major component of high density lipoprotein, while Apo B which is a primary apolipoprotein of chylomicrons, VLDL, IDL, and LDL when in reference to both heart and vascular diseases indictment, helps in the transportation of fat molecules (lipids): cholesterol inclusive around the body. The study was carried out to compare Apo A1 and Apo levels in women on Implanon, Jadelle and Depo-Provera- the three most popular steroidal contraceptives used in south-south part of Nigeria.
Methodology: Ninety (90) female subjects in three groups of 30 each were recruited for Implanon, Jadelle and Depo-provera. Apo A1 and Apo B were determined using turbidimetric method on Baseline, 3rd, 6th, 9th and 12th month blood samples collected from these subjects.
Result: The result of the study showed that there was increased significant difference in Apo A concentration of females on Implanon, Jadelle and Depo-provera at 3rd, 6th, 9th and 12th months compared with the baseline. Also, a significant increased difference (P<0.05) was observed at the 3rd, 6th, 9th and 12th month in ApoB when compared with the baseline. A monthly dependent increase was observed in the three contraceptives studied for ApoB, a pattern which is also observed in ApoA1 in jadelle and depo-provera only.
Conclusion: The study showed that there were significant increased changes in Apo A1 and ApoB concentrations in female subjects taking Implanon, Jadelle and Depo-provera at different months.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2020 International Journal of Biomedical and Advance Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).